“Dual use of artificial-intelligence-powered drug discovery” Fabio Urbina, Filippa Lentzos, Cedric Invernizzi, Sean Ekins, March7th, 2022  

“Biosecurity in the Age of AI” HELENA , July 2023  

“Artificial intelligence and biological misuse: Differentiating risks of language models and biological design tools” Jonas B. Sandbrink, August 5th, 2023 

Assessing the Risks Posed by the Convergence of Artificial Intelligence and Biotechnology”  John T. O’Brien, Cassidy Nelson, June 2020  

“Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA”  Department of Health and Human Services